Dishant Gupta was director of strategy and operations in the Cambridge office of Ipsen where he learned from co-workers that Ipsen was intent on buying Epizyme in early 2022.
Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...
Scholar Rock yesterday reported that its experimental treatment for spinal muscular atrophy succeeded in a Phase 3 trial, ...